Matthew T. Harbison

Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.

Christiane J. Bruns, Carmen C. Solórzano, Matthew T. Harbison et al. · PubMed · 2000 · 501 citations

Endothelial Cells, Chemoprevention Strategy, Pathology +16

Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.

Christiane J. Bruns, Matthew T. Harbison, Darren W. Davis et al. · PubMed · 2000 · 422 citations

Pathology, Dermatology, Anti-egf-r Antibody C225 +18

In Vivo Selection and Characterization of Metastatic Variants from Human Pancreatic Adenocarcinoma by Using Orthotopic Implantation in Nude Mice

Christiane J. Bruns, Matthew T. Harbison, Hiroki Kuniyasu et al. · Neoplasia · 1999 · 347 citations · Full text

Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts.

Steffan T. Nawrocki, Christiane J. Bruns, Matthew T. Harbison et al. · PubMed · 2002 · 172 citations

Chemoprevention Strategy, Apoptosis, Immunology +16

CREB and Its Associated Proteins Act as Survival Factors for Human Melanoma Cells

Didier Jean, Matthew T. Harbison, David J. McConkey et al. · Journal of Biological Chemistry · 1998 · 165 citations · Full text